The increasing incidence of thyroid cancer: The influence of access to care

Thyroid

Volumn 23, Issue 7, 2013, Pages 885-891

  Morris, Luc G T ^a   Sikora, Andrew G ^b   Tosteson, Tor D ^c   Davies, Louise ^d,e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d VA MEDICAL CENTER   (United States)

^e DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; EDUCATIONAL STATUS; EMPLOYMENT; HEALTH CARE ACCESS; HEALTH INSURANCE; HUMAN; INCOME; POVERTY; PRIORITY JOURNAL; THYROID CANCER; UNITED STATES;

ADULT; AGED; ASYMPTOMATIC DISEASES; CARCINOMA; DIAGNOSTIC ERRORS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; SEER PROGRAM; THYROID NEOPLASMS; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 84881464304     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0045     Document Type: Article

References (46)

1. Davies L, Ouellette M, Hunter M, Welch HG 2010 The increasing incidence of small thyroid cancers: Where are the cases coming from? Laryngoscope 120:2446-2451
2. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. Jama 295:2164-2167
3. Morris LG, Myssiorek D 2010 Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: A population-based analysis. Am J Surg 200: 454-461
4. Morris LG, Sikora AG, Myssiorek D, DeLacure MD 2008 The basis of racial differences in the incidence of thyroid cancer. Ann Surg Oncol 15:1169-1176
5. Burgess JR 2002 Temporal trends for thyroid carcinoma in Australia: An increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 12:141-149
6. Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace- Lesech J, Velten M, Guizard A, Tretarre B, Buemi AV, Arveux P, Esteve J 2002 Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 38:1762-1768
7. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N 2009 International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20:525-531
8. Liu S, Semenciw R, Ugnat AM, Mao Y 2001 Increasing thyroid cancer incidence in Canada, 1970-1996: Time trends and age-period-cohort effects. Br J Cancer 85:1335-1339
9. Leenhardt L, Grosclaude P, Cherie-Challine L 2004 Increased incidence of thyroid carcinoma in france: A true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056-1060
10. Chen AY, Jemal A, Ward EM 2009 Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115:3801-3807
11. Grodski S, Brown T, Sidhu S, Gill A, Robinson B, Learoyd D, Sywak M, Reeve T, Delbridge L 2008 Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144:1038-1043; discussion 1043
12. Welch HG, Black WC 2010 Overdiagnosis in cancer. J Natl Cancer Inst 102:605-613
13. Harach HR, Franssila KO, Wasenius VM 1985 Occult papillary carcinoma of the thyroid. A ''normal'' finding in Finland. A systematic autopsy study. Cancer 56:531-538
14. Tanriover O, Comunoglu N, Eren B, Comunoglu C, Turkmen N, Dogan M, Gundogmus UN 2011 Occult papillary thyroid carcinoma: Prevalence at autopsy in Turkish people. Eur J Cancer Prev 20:308-312
15. Valle LA, Kloos RT The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab 96:E109-113
16. Birnbaum M, Patchias EM 2010 Measuring coverage for seniors in Medicare Part A and estimating the cost of making it universal. J Health Polit Policy Law 35:49-62
17. DeNavas-Walt C, Proctor BD, Smith JC 2012 Income, Poverty, and Health Insurance Coverage in the United States: 2011. Vol P60-243. U.S. Government Printing Office, Washington, D.C.
18. Clarke CA, Moy LM, Swetter SM, Zadnick J, Cockburn MG 2010 Interaction of area-level socioeconomic status and UV radiation on melanoma occurrence in California. Cancer Epidemiol Biomarkers Prev 19:2727-2733
19. Mackillop WJ, Zhang-Salomons J, Boyd CJ, Groome PA 2000 Associations between community income and cancer incidence in Canada and the United States. Cancer 89:901-912
20. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, Goodman MT, Lynch CF, Schwartz SM, Chen VW, Bernstein L, Gomez SL, Graff JJ, Lin CC, Johnson NJ, Edwards BK 2009 Impact of socioeconomic status on cancer incidence and stage at diagnosis: Selected findings from the Surveillance, Epidemiology, and End Results: National Longitudinal Mortality Study. Cancer Causes Control 20: 417-435
21. Hao Y, Jemal A, Zhang X, Ward EM 2009 Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995-2004 (United States). Cancer Causes Control 20:1855-1863
22. Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC 2009 Trends in area-socioeconomic and raceethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev 18:121-131
23. Klassen AC, Curriero FC, Hong JH, Williams C, Kulldorff M, Meissner HI, Alberg A, Ensminger M 2004 The role of arealevel influences on prostate cancer grade and stage at diagnosis. Prev Med 39:441-448
24. Schootman M, Lian M, Deshpande AD, Baker EA, Pruitt SL, Aft R, Jeffe DB 2010 Temporal trends in geographic disparities in small-area breast cancer incidence and mortality, 1988 to 2005. Cancer Epidemiol Biomarkers Prev 19:1122-1131
25. Singh GK, Miller BA, Hankey BF, Edwards BK 2004 Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 101:1051-1057
26. Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ, Schwartz SM, Bernstein L, Chen VW, Goodman MT, Gomez SL, Graff JJ, Lynch CF, Lin CC, Edwards BK 2007 Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: Implications for health disparity studies. Cancer Causes Control 18:177-187
27. National Cancer Institute. SEER. Surveillance, Epidemiology, and End Results program data, 1973-2009. Available at http://seer.cancer.gov/data (accessed February 1, 2013).
28. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF 2002 Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94:1537-1545
29. Clegg LX, Gail MH, Feuer EJ 2002 Estimating the variance of disease-prevalence estimates from population-based registries. Biometrics 58:684-688
30. Zippin C, Lum D, Hankey BF 1995 Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 76:2343-2350
31. United States Census Bureau. Census 2000 Gateway. Available at www.census.gov/main/www/cen2000.html (accessed February 1, 2013).
32. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (eds) 2000 International classification of diseases for oncology, 3rd ed. World Health Organization, Geneva
33. O'Hara B 2008 Experimental health insurance estimates for low-income and demographic groups by state. Health Serv Res 43(5p1):1693-1707
34. Gigli A, Mariotto A, Clegg LX, Tavilla A, Corazziari I, Capocaccia R, Hachey M, Steve S 2006 Estimating the variance of cancer prevalence from population-based registries. Stat Methods Med Res 15:235-253
35. Breslow NE, Clayton DG 1993 Approximate inference in generalized linear mixed models. J Am Stat Assoc 88:9-25
36. Surveillance Research Program 2012 Age adjusted U.S. mortality rates and 95% confidence intervals by cancer site. National Cancer Institute, Bethesda, MD. Available online at http://seer.cancer.gov/statistics (accessed February 1, 2013).
37. Li N, Du XL, Reitzel LR, Xu L, Sturgis EM Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: Review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid 23:103-110
38. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 21:125-134
39. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ 2002 Overdiagnosis due to prostatespecific antigen screening: Lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94:981-990
40. Cheng I, Witte JS, McClure LA, Shema SJ, Cockburn MG, John EM, Clarke CA 2009 Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control 20:1431- 1440
41. Liu L, Cozen W, Bernstein L, Ross RK, Deapen D 2001 Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst 93:705-709
42. Steenland K, Rodriguez C, Mondul A, Calle EE, Thun M 2004 Prostate cancer incidence and survival in relation to education (United States). Cancer Causes Control 15:939- 945
43. 1976 Information for physicians on irradiation related thyroid cancer. CA Cancer J Clin 26:150-159
44. Ron E, Saftlas AF 1996 Head and neck radiation carcinogenesis: Epidemiologic evidence. Otolaryngol Head Neck Surg 115:403-408
45. Sinnott B, Ron E, Schneider AB 2010 Exposing the thyroid to radiation: A review of its current extent, risks, and implications. Endocr Rev 31:756-773
46. Brenner DJ, Hall EJ 2007 Computed tomography- an increasing source of radiation exposure. N Engl J Med 357:2277-2284